SCHEMBL21609013

SCHEMBL21609013

COC(=O)c1ccc2c(NS(=O)(=O)c3ccc(OC)cc3OC)noc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 7/20 0.60
KAT7 O95251 6/20 0.60
KAT6B Q8WYB5 2/20 0.49
KAT5 Q92993 1/20 0.49
KAT8 Q9H7Z6 1/20 0.49
GAA P10253 5/20 0.48
PKM P14618 1/20 0.48
BRD4 O60885 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CDK5 Q00535 1/20 0.45
CDK5R1 Q15078 1/20 0.45
CYP2C9 P11712 2/20 0.45
ALPL P05186 1/20 0.44
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TSHR P16473 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29652390 1.00 KAT6A (0.60) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL31605611 0.84 KAT6A (0.70) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL21596897 0.84 KAT6A (0.70) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL31510913 0.83 KAT6A (0.45) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL21609026 0.83 KAT6A (0.67) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL21641910 0.79 KAT6A (0.72) KAT6AKAT7KAT6BBRD4MEN1
SCHEMBL31605558 0.79 KAT6A (0.56) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL21609150 0.79 KAT6A (0.56) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL31605606 0.78 KAT6A (0.56) KAT6AKAT7KAT6BKAT5KAT8
SCHEMBL21596856 0.78 KAT6A (0.56) KAT6AKAT7KAT6BKAT5KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 KAT6A 877/4885KAT7 490/4885KAT6B 1005/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 KAT6A 878/4885KAT7 490/4885KAT6B 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.